MYMX (Mymetics) Cyclically Adjusted Revenue per Share: $0.00 (As of Sep. 2023)


MYMX Mymetics Corp MYMX
12 GF Score
Price $0.00
View Full Analysis

What is Mymetics Cyclically Adjusted Revenue per Share?

Mymetics MYMX 12 Cyclically Adjusted Revenue per Share is $0.00 as of Sep. 2023. GuruFocus rates MYMX with a GF Score™ of 12/100.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Mymetics's adjusted revenue per share for the three months ended in Sep. 2023 was $0.000. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $0.00 for the trailing ten years ended in Sep. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-07-12), Mymetics's current stock price is $0.0003. Mymetics's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2023 was $0.00. Mymetics's Cyclically Adjusted PS Ratio of today is .


Mymetics  (OTCPK:MYMX) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Mymetics Cyclically Adjusted Revenue per Share Related Terms


Mymetics Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Mymetics's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mymetics Cyclically Adjusted Revenue per Share Chart

Mymetics Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 13.46 13.47 0.00 14.80

Mymetics Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 14.80 14.47 0.00 0.00

MYMX vs RBSH, NBRVF, TMBRQ: Cyclically Adjusted Revenue per Share Comparison

For the Biotechnology subindustry, Mymetics's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mymetics Cyclically Adjusted PS Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mymetics's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Mymetics's Cyclically Adjusted PS Ratio falls into.


MYMX
12GF Score
Mymetics Corp MYMX
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mymetics Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Mymetics's adjusted Revenue per Share data for the three months ended in Sep. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=0/106.5695*106.5695
=0.000

Current CPI (Sep. 2023) = 106.5695.

Mymetics Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201312 39.047 101.036 41.186
201403 4.893 101.224 5.151
201406 4.605 101.517 4.834
201409 5.382 101.247 5.665
201412 5.855 100.704 6.196
201503 4.711 100.339 5.004
201506 7.592 100.464 8.053
201509 5.125 99.785 5.473
201512 5.500 99.386 5.898
201603 2.967 99.475 3.179
201606 2.388 100.088 2.543
201609 1.322 99.604 1.414
201612 2.401 99.380 2.575
201703 0.730 100.040 0.778
201706 0.724 100.285 0.769
201709 3.132 100.254 3.329
201712 -6.987 100.213 -7.430
201803 0.000 100.836 0.000
201806 0.000 101.435 0.000
201809 0.579 101.246 0.609
201812 0.000 100.906 0.000
201903 0.000 101.571 0.000
201906 0.000 102.044 0.000
201909 0.000 101.396 0.000
201912 0.809 101.063 0.853
202003 0.125 101.048 0.132
202006 0.079 100.743 0.084
202009 0.000 100.585 0.000
202012 0.059 100.241 0.063
202103 0.026 100.800 0.027
202106 0.000 101.352 0.000
202109 0.000 101.533 0.000
202112 0.000 101.776 0.000
202203 0.020 103.205 0.021
202206 0.000 104.783 0.000
202209 0.000 104.835 0.000
202212 0.020 104.666 0.020
202303 0.020 106.245 0.020
202306 0.000 106.576 0.000
202309 0.000 106.570 0.000

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $0.00 mean?
Mymetics (MYMX) has a Cyclically Adjusted Revenue per Share of $0.00 as of Sep. 2023. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Mymetics and its competitors.
Is Mymetics' Cyclically Adjusted Revenue per Share too high?
Mymetics' current Cyclically Adjusted Revenue per Share is $0.00. Overall, Mymetics has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Mymetics' Cyclically Adjusted Revenue per Share compare to RBSH and NBRVF?
Mymetics' Cyclically Adjusted Revenue per Share of $0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Biotechnology company?
A good Cyclically Adjusted Revenue per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Mymetics and its competitors. Mymetics's current Cyclically Adjusted Revenue per Share is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mymetics stock overvalued right now?
Mymetics (MYMX) has a current Cyclically Adjusted Revenue per Share of $0.00. The current Cyclically Adjusted Revenue per Share is $0.00. Mymetics' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Mymetics (MYMX), the current Cyclically Adjusted Revenue per Share is $0.00 as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Mymetics Business Description

Address Route de la Corniche 4, Epalinges, CHE, CH-1066
Mymetics Corp is a vaccine company and is focused on the research and development of next-generation vaccines for infectious and life-disabling diseases. Its vaccine candidates in the pipeline include HIV-1/AIDS, malaria, and Covid-19, and intranasal influenza, RSV, Chikungunya, and HSV vaccine candidate programs.
12GF Score

Get the complete analysis for MYMX

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price